Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in Am J Nephrol

Retrieve available abstracts of 196 articles:
HTML format



Single Articles


    April 2021
  1. NAVARRETE JE, Tong DC, Cobb J, Rahbari-Oskoui FF, et al
    Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population.
    Am J Nephrol. 2021 Apr 7:1-9. doi: 10.1159/000514752.
    PubMed     Abstract available


    March 2021
  2. FENG Y, Jones MR, Chu NM, Segev DL, et al
    Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis.
    Am J Nephrol. 2021 Mar 31:1-11. doi: 10.1159/000514233.
    PubMed     Abstract available


  3. MOROMIZATO T, Kohagura K, Tokuyama K, Shiohira Y, et al
    Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis.
    Am J Nephrol. 2021 Mar 23:1-11. doi: 10.1159/000513951.
    PubMed     Abstract available


  4. THURLOW JS, Joshi M, Yan G, Norris KC, et al
    Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.
    Am J Nephrol. 2021 Mar 22:1-10. doi: 10.1159/000514550.
    PubMed     Abstract available


  5. CHO ME, Sweeney C, Fino N, Greene T, et al
    Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
    Am J Nephrol. 2021 Mar 18:1-11. doi: 10.1159/000514302.
    PubMed     Abstract available


  6. KIM AJ, Ro H, Kim H, Chang JH, et al
    Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes.
    Am J Nephrol. 2021 Mar 16:1-12. doi: 10.1159/000513663.
    PubMed     Abstract available


    February 2021
  7. PAI AY, Wenziger C, Streja E, Argueta DA, et al
    Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients.
    Am J Nephrol. 2021 Feb 18:1-10. doi: 10.1159/000513381.
    PubMed     Abstract available


  8. JIANG J, Zhang Y, Chen J, Yang X, et al
    Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis.
    Am J Nephrol. 2021 Feb 17:1-9. doi: 10.1159/000512385.
    PubMed     Abstract available


  9. NANGAKU M, Hamano T, Akizawa T, Tsubakihara Y, et al
    Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
    Am J Nephrol. 2021 Feb 9:1-10. doi: 10.1159/000513103.
    PubMed     Abstract available


  10. SANAI T, Okamura K, Onoue T, Ono T, et al
    Hemodilution Impacts Assessment of Thyroid Status before and after Hemodialysis in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2021;51:988-994.
    PubMed     Abstract available


    January 2021
  11. OLANIRAN KO, Eneanya ND, Zhao SH, Ofsthun NJ, et al
    Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating Dialysis.
    Am J Nephrol. 2021 Jan 22:1-9. doi: 10.1159/000513012.
    PubMed     Abstract available


  12. PARK HC, Kwon YE, Choi HY, Oh HJ, et al
    Health Insurance Status Is Related to Risk of Mortality and Hospitalization in Korean Maintenance Hemodialysis Patients: A Longitudinal Cohort Study.
    Am J Nephrol. 2021 Jan 13:1-7. doi: 10.1159/000512855.
    PubMed     Abstract available


    October 2020
  13. GOLIGORSKY MS
    NET Formation in Dialysis: A Valuable, albeit Mysterious and Enticing Predictor of Mortality.
    Am J Nephrol. 2020 Oct 26:1-3. doi: 10.1159/000510772.
    PubMed    


  14. EINBINDER Y, Shnaider A, Ghanayem K, Basok A, et al
    Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality.
    Am J Nephrol. 2020 Oct 26:1-9. doi: 10.1159/000510771.
    PubMed     Abstract available


  15. YANG Y, Qin X, Li Y, Yang S, et al
    Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study.
    Am J Nephrol. 2020 Oct 16:1-10. doi: 10.1159/000509258.
    PubMed     Abstract available


    September 2020
  16. DANESE MD, Lubeck D, Belozeroff V, Lin TC, et al
    Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.
    Am J Nephrol. 2020 Sep 23:1-8. doi: 10.1159/000510360.
    PubMed     Abstract available


  17. BENILLOUCHE E, Ostertag A, Marty C, Urena Torres P, et al
    Cortical Bone Microarchitecture in Dialysis Patients.
    Am J Nephrol. 2020 Sep 10:1-6. doi: 10.1159/000510064.
    PubMed     Abstract available


  18. JOTWANI V, Garimella PS, Katz R, Malhotra R, et al
    Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.
    Am J Nephrol. 2020 Sep 9:1-9. doi: 10.1159/000509978.
    PubMed     Abstract available


    August 2020
  19. MOORTHI RN, Fadel WF, Cranor A, Hindi J, et al
    Mobility Impairment in Patients New to Dialysis.
    Am J Nephrol. 2020 Aug 11:1-10. doi: 10.1159/000509225.
    PubMed     Abstract available


  20. YOU AS, Kalantar-Zadeh K, Streja E, Park C, et al
    Mortality Risk in Chronic Kidney Disease Patients Transitioning to Dialysis: Impact of Opiate and Non-Opiate Use.
    Am J Nephrol. 2020 Aug 10:1-11. doi: 10.1159/000509451.
    PubMed     Abstract available


  21. LANKINEN R, Hakamaki M, Metsarinne K, Koivuviita NS, et al
    Cardiovascular Determinants of Mortality in Advanced Chronic Kidney Disease.
    Am J Nephrol. 2020 Aug 10:1-10. doi: 10.1159/000509582.
    PubMed     Abstract available


    July 2020
  22. ISHIWATARI A, Yamamoto S, Fukuma S, Hasegawa T, et al
    Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice Patterns.
    Am J Nephrol. 2020 Jul 31:1-9. doi: 10.1159/000509309.
    PubMed     Abstract available


  23. SACHDEVA M, Uppal NN, Hirsch JS, Ng JH, et al
    COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case Series.
    Am J Nephrol. 2020 Jul 30:1-5. doi: 10.1159/000510259.
    PubMed     Abstract available


  24. ALEXANDROU ME, Balafa O, Sarafidis P
    Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques.
    Am J Nephrol. 2020 Jul 27:1-24. doi: 10.1159/000509115.
    PubMed     Abstract available


  25. SCHAMROTH PRAVDA M, Cohen Hagai K, Topaz G, Schamroth Pravda N, et al
    Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis.
    Am J Nephrol. 2020 Jul 22:1-6. doi: 10.1159/000508836.
    PubMed     Abstract available


  26. AGARWAL R, Cramer AE, Balmes-Fenwick M, Sinha AD, et al
    Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial.
    Am J Nephrol. 2020;51:542-552.
    PubMed     Abstract available


  27. CHU NM, Chen X, Norman SP, Fitzpatrick J, et al
    Frailty Prevalence in Younger End-Stage Kidney Disease Patients Undergoing Dialysis and Transplantation.
    Am J Nephrol. 2020 Jul 8:1-10. doi: 10.1159/000508576.
    PubMed     Abstract available


    June 2020
  28. DEBNATH S, Lorenzo C, Bansal S, Morales J, et al
    Branched-Chain Amino Acids Depletion during Hemodialysis Is Associated with Fatigue.
    Am J Nephrol. 2020 Jun 23:1-7. doi: 10.1159/000507839.
    PubMed     Abstract available


    May 2020
  29. WADDY SP, Becerra AZ, Ward JB, Chan KE, et al
    Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.
    Am J Nephrol. 2020 May 19:1-9. doi: 10.1159/000507725.
    PubMed     Abstract available


    April 2020
  30. XU X, Wang L, Xiong M, Nie S, et al
    New Criterion to Evaluate Acute-on-Chronic Kidney Injury Based on the Creatinine Reference Change.
    Am J Nephrol. 2020 Apr 29:1-10. doi: 10.1159/000506664.
    PubMed     Abstract available


  31. TUMMALAPALLI SL, Vittinghoff E, Crews DC, Cushman M, et al
    Chronic Kidney Disease Awareness and Longitudinal Health Outcomes: Results from the REasons for Geographic And Racial Differences in Stroke Study.
    Am J Nephrol. 2020 Apr 29:1-10. doi: 10.1159/000507774.
    PubMed     Abstract available


  32. BHANDARI S, Allgar V, Lamplugh A, Macdougall IC, et al
    Protocol and Baseline Data of a Multicentre Prospective Double-Blinded Randomized Study of Intravenous Iron on Functional Status in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2020 Apr 29:1-8. doi: 10.1159/000507872.
    PubMed     Abstract available


  33. EL SHAMY O, Tran H, Sharma S, Ronco C, et al
    Telenephrology with Remote Peritoneal Dialysis Monitoring during Coronavirus Disease 19.
    Am J Nephrol. 2020 Apr 28:1-3. doi: 10.1159/000508023.
    PubMed    


  34. ALI H, Sharma A, Halawa A
    Effect of Interleukin-2 Receptor Antibody Induction Therapy on Survival in Renal Transplant Patients Receiving Tacrolimus.
    Am J Nephrol. 2020 Apr 8:1-7. doi: 10.1159/000506970.
    PubMed     Abstract available


  35. SCHOINA M, Loutradis C, Minopoulou I, Theodorakopoulou M, et al
    Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney Disease.
    Am J Nephrol. 2020 Apr 7:1-10. doi: 10.1159/000507416.
    PubMed     Abstract available


    March 2020
  36. FERREY AJ, Choi G, Hanna RM, Chang Y, et al
    A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.
    Am J Nephrol. 2020 Mar 28:1-6. doi: 10.1159/000507417.
    PubMed     Abstract available


  37. WEIR MR, McCullough PA, Buse JB, Anderson J, et al
    Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation
    Am J Nephrol. 2020 Mar 13:1-13. doi: 10.1159/000506533.
    PubMed     Abstract available


  38. BIRUETE A, Srinivasan S, O'Neill KD, Vorland CJ, et al
    Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.
    Am J Nephrol. 2020 Mar 6:1-9. doi: 10.1159/000506729.
    PubMed     Abstract available


    February 2020
  39. ALLEGRETTI AS, Endres P, Parris T, Zhao S, et al
    Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit.
    Am J Nephrol. 2020 Feb 25:1-9. doi: 10.1159/000506412.
    PubMed     Abstract available


  40. GIL-ORTEGA M, Vega-Martin E, Martin-Ramos M, Gonzalez-Blazquez R, et al
    Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Fromter Rats, a Genetic Model of Chronic Kidney Disease.
    Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.
    PubMed     Abstract available


  41. UITERWIJK H, Franssen CFM, Kuipers J, Westerhuis R, et al
    Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting Peritonitis.
    Am J Nephrol. 2020 Feb 18:1-7. doi: 10.1159/000506324.
    PubMed     Abstract available


  42. LIOUFAS NM, Pedagogos E, Hawley CM, Pascoe EM, et al
    Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the IMpact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Am J Nephrol. 2020 Feb 5:1-15. doi: 10.1159/000505717.
    PubMed     Abstract available


  43. WETMORE JB, Yan H, Gilbertson DT, Liu J, et al
    Factors Associated with Elective Withdrawal of Maintenance Hemodialysis: A Case-Control Analysis.
    Am J Nephrol. 2020 Feb 4:1-10. doi: 10.1159/000505993.
    PubMed     Abstract available


    January 2020
  44. CHOI SJ, Obi Y, Ko GJ, You AS, et al
    Comparing Patient Survival of Home Hemodialysis and Peritoneal Dialysis Patients.
    Am J Nephrol. 2020 Jan 28:1-9. doi: 10.1159/000504691.
    PubMed     Abstract available


  45. ALI W, Gao G, Bakris GL
    Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
    Am J Nephrol. 2020 Jan 24:1-5. doi: 10.1159/000505895.
    PubMed     Abstract available


  46. MORADI H, Park C, Streja E, Argueta DA, et al
    Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Am J Nephrol. 2020 Jan 14:1-10. doi: 10.1159/000505444.
    PubMed     Abstract available


  47. INAMI T, Lyons OD, Perger E, Yadollahi A, et al
    Effect of Ultrafiltration on Sleep Apnea and Cardiac Function in End-Stage Renal Disease.
    Am J Nephrol. 2020 Jan 14:1-8. doi: 10.1159/000505445.
    PubMed     Abstract available


  48. BEBERASHVILI I
    Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis Patients.
    Am J Nephrol. 2020 Jan 14:1-3. doi: 10.1159/000505446.
    PubMed    


  49. SAEED F, Adams H, Epstein RM
    Matters of Life and Death: Why Do Older Patients Choose Conservative Management?
    Am J Nephrol. 2020;51:35-42.
    PubMed     Abstract available


    December 2019
  50. QIAN JZ, McAdams-DeMarco MA, Ng D, Lau B, et al
    Validation of a Risk Equation Predicting Hemodialysis Arteriovenous Fistula Primary Failure in Elderly.
    Am J Nephrol. 2019;51:17-23.
    PubMed     Abstract available


  51. BRAVO GONZALEZ-BLAS L, Garcia-Gago L, Astudillo-Jarrin D, Rodriguez-Magarinos C, et al
    Analysis of Factors Influencing the Prognostic Significance of Hyponatremia in Peritoneal Dialysis Patients.
    Am J Nephrol. 2019 Dec 6:1-11. doi: 10.1159/000504870.
    PubMed     Abstract available


    November 2019
  52. MA Q, Su D, Liu F, Xing H, et al
    Parathyroidectomy Influences Coronary Artery Calcium Score in Asymptomatic Hemodialysis Patients with Secondary Hyperparathyroidism.
    Am J Nephrol. 2019 Nov 26:1-9. doi: 10.1159/000503806.
    PubMed     Abstract available


  53. KITTISKULNAM P, Srijaruneruang S, Chulakadabba A, Thokanit NS, et al
    Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Am J Nephrol. 2019 Nov 21:1-11. doi: 10.1159/000504557.
    PubMed     Abstract available


  54. JAWED A, Moe SM, Moorthi RN, Torke AM, et al
    Increasing Nephrologist Awareness of Symptom Burden in Older Hospitalized End-Stage Renal Disease Patients.
    Am J Nephrol. 2019 Nov 19:1-6. doi: 10.1159/000504333.
    PubMed     Abstract available


    October 2019
  55. GUILLOUET S, Boyer A, Lanot A, Ficheux M, et al
    Assessment for Assisted Peritoneal Dialysis by Peritoneal Dialysis Nurses: Results of a Cohort Study.
    Am J Nephrol. 2019 Oct 31:1-10. doi: 10.1159/000503622.
    PubMed     Abstract available


  56. LEE Y, Okuda Y, Sy J, Kim SR, et al
    Ultrafiltration Rate Effects Declines in Residual Kidney Function in Hemodialysis Patients.
    Am J Nephrol. 2019 Oct 29:1-8. doi: 10.1159/000503918.
    PubMed     Abstract available


  57. CHERNIN G, Chen S, Ozan O, Liu M, et al
    Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2019 Oct 25:1-8. doi: 10.1159/000503916.
    PubMed     Abstract available


  58. BAKRIS GL, Agarwal R, Anker SD, Pitt B, et al
    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
    Am J Nephrol. 2019 Oct 25:1-12. doi: 10.1159/000503713.
    PubMed     Abstract available


  59. WU CC, Hsieh MY, Lee CK, Chuang SY, et al
    Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.
    Am J Nephrol. 2019 Oct 22:1-11. doi: 10.1159/000503949.
    PubMed     Abstract available


  60. MODI GK, Jha V
    Disparate Chronic Kidney Disease-Associated Outcomes in South Asians Ethnicity or Estimated Glomerular Filtration Rate?
    Am J Nephrol. 2019 Oct 22:1-3. doi: 10.1159/000503874.
    PubMed    


  61. FIRTH C, Kaur T, Chakkera H, Zhang N, et al
    Cardiac Troponin T and Right Ventricular Systolic Pressure Predict Cardiovascular and Mortality Risk in Kidney Transplant Candidates.
    Am J Nephrol. 2019 Oct 22:1-10. doi: 10.1159/000503807.
    PubMed     Abstract available


  62. LI T, Wilcox CS, Lipkowitz MS, Gordon-Cappitelli J, et al
    Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.
    Am J Nephrol. 2019 Oct 18:1-11. doi: 10.1159/000503805.
    PubMed     Abstract available


  63. NADEAU-FREDETTE AC, Chan CT, Bargman JM, Copland MA, et al
    Predictors of Care Gaps in Home Dialysis: The Home Dialysis Virtual Ward Study.
    Am J Nephrol. 2019 Oct 10:1-9. doi: 10.1159/000503439.
    PubMed     Abstract available


    September 2019
  64. ERIGUCHI R, Obi Y, Soohoo M, Rhee CM, et al
    Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
    Am J Nephrol. 2019 Sep 13:1-9. doi: 10.1159/000502998.
    PubMed     Abstract available


  65. HARA T, Kimachi M, Ikenoue T, Akizawa T, et al
    Intra-Dialytic Hemoglobin Changes and Cardiovascular Events: A Cohort Study on Dialysis Outcomes and Practice Patterns in Japan.
    Am J Nephrol. 2019 Sep 5:1-9. doi: 10.1159/000502633.
    PubMed     Abstract available


  66. LU Y, Wang Y, Lu Q
    Effects of Exercise on Muscle Fitness in Dialysis Patients: A Systematic Review and Meta-Analysis.
    Am J Nephrol. 2019 Sep 3:1-12. doi: 10.1159/000502635.
    PubMed     Abstract available


  67. SCHEFOLD JC, Krag M, Marker S, Perner A, et al
    Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.
    Am J Nephrol. 2019 Sep 3:1-8. doi: 10.1159/000502732.
    PubMed     Abstract available


    August 2019
  68. GHOSHAL S, Freedman BI
    Mechanisms of Stroke in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2019 Aug 28:1-11. doi: 10.1159/000502446.
    PubMed     Abstract available


  69. HUANG M, Lv A, Wang J, Xu N, et al
    Exercise Training and Outcomes in Hemodialysis Patients: Systematic Review and Meta-Analysis.
    Am J Nephrol. 2019 Aug 27:1-15. doi: 10.1159/000502447.
    PubMed     Abstract available


  70. NORDYKE RJ, Reichert H, Bylsma LC, Jackson JJ, et al
    Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage.
    Am J Nephrol. 2019 Aug 21:1-9. doi: 10.1159/000502507.
    PubMed     Abstract available


  71. BUGEJA A, Harris S, McCormick B, Brown PA, et al
    Safety and Efficacy of Tinzaparin Anticoagulation during Nocturnal Hemodialysis.
    Am J Nephrol. 2019 Aug 21:1-7. doi: 10.1159/000502506.
    PubMed     Abstract available


  72. AL-BALAS A, Shariff S, Lee T, Young C, et al
    Clinical Outcomes and Economic Impact of Starting Hemodialysis with a Catheter after Predialysis Arteriovenous Fistula Creation.
    Am J Nephrol. 2019 Aug 8:1-7. doi: 10.1159/000502050.
    PubMed     Abstract available


  73. LEWIS JR, Wong G, Taverniti A, Vucak-Dzumhur M, et al
    Association between Aortic Calcification, Cardiovascular Events, and Mortality in Kidney and Pancreas-Kidney Transplant Recipients.
    Am J Nephrol. 2019 Aug 8:1-10. doi: 10.1159/000502328.
    PubMed     Abstract available


  74. COURI T, Katz J, Stoeckle K, Nugooru A, et al
    Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.
    Am J Nephrol. 2019 Aug 7:1-9. doi: 10.1159/000502049.
    PubMed     Abstract available


    July 2019
  75. HUML AM, Sehgal AR
    Hemodialysis Quality Metrics in the First Year Following a Failed Kidney Transplant.
    Am J Nephrol. 2019 Jul 16:1-7. doi: 10.1159/000501605.
    PubMed     Abstract available


  76. WONG E, Ballew SH, Daya N, Ishigami J, et al
    Hospitalization Risk among Older Adults with Chronic Kidney Disease.
    Am J Nephrol. 2019 Jul 16:1-9. doi: 10.1159/000501539.
    PubMed     Abstract available


  77. KU E, McCulloch CE, Johansen KL
    Starting Renal Replacement Therapy: Is It About Time?
    Am J Nephrol. 2019 Jul 3:1-8. doi: 10.1159/000501510.
    PubMed     Abstract available


    June 2019
  78. FARRINGTON CA, Allon M
    Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting Organism.
    Am J Nephrol. 2019 Jun 26:1-7. doi: 10.1159/000501357.
    PubMed     Abstract available


  79. CANNEY M, Djurdjev O, Tang M, Zierold C, et al
    GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
    Am J Nephrol. 2019 Jun 25:1-10. doi: 10.1159/000501189.
    PubMed     Abstract available


  80. DAVIS-AJAMI ML, Fink JC, Baernholdt M, Wu J, et al
    Adverse Safety Event Characteristics and Predictive Factors in Hospital Encounters for Patients with Chronic Kidney Disease.
    Am J Nephrol. 2019 Jun 19:1-9. doi: 10.1159/000500562.
    PubMed     Abstract available


  81. WEINHANDL ED, Ray D, Kubisiak KM, Collins AJ, et al
    Contemporary Trends in Clinical Outcomes among Dialysis Patients with Medicare Coverage.
    Am J Nephrol. 2019 Jun 14:1-9. doi: 10.1159/000500943.
    PubMed     Abstract available


  82. OKADA Y, Uehara S, Shibata M, Koh H, et al
    Habitual Alcohol Intake Modifies Relationship of Uric Acid to Incident Chronic Kidney Disease.
    Am J Nephrol. 2019 Jun 6:1-8. doi: 10.1159/000500707.
    PubMed     Abstract available


  83. GREGG LP, Jain N, Carmody T, Minhajuddin AT, et al
    Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes.
    Am J Nephrol. 2019 Jun 5:1-11. doi: 10.1159/000500668.
    PubMed     Abstract available


  84. LEE J, Chu C, Guzman D, Fontil V, et al
    Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes.
    Am J Nephrol. 2019 Jun 5:1-7. doi: 10.1159/000500706.
    PubMed     Abstract available


    May 2019
  85. KUIPERS J, Verboom LM, Ipema KJR, Paans W, et al
    The Prevalence of Intradialytic Hypotension in Patients on Conventional Hemodialysis: A Systematic Review with Meta-Analysis.
    Am J Nephrol. 2019;49:497-506.
    PubMed     Abstract available


  86. VAN BUREN PN
    Redefining the Burden of Intradialytic Hypotension in the Modern Era of Hemodialysis.
    Am J Nephrol. 2019;49:494-496.
    PubMed    


  87. PARMAR DV, Kansagra KA, Patel JC, Joshi SN, et al
    Outcomes of Desidustat Treatment in People with Anemia and Chronic Kidney Disease: A Phase 2 Study.
    Am J Nephrol. 2019;49:470-478.
    PubMed     Abstract available


  88. DREW DA, Tighiouart H, Duncan S, Rollins J, et al
    Blood Pressure and Cognitive Decline in Prevalent Hemodialysis Patients.
    Am J Nephrol. 2019;49:460-469.
    PubMed     Abstract available


    April 2019
  89. GORAYA N, Munoz-Maldonado Y, Simoni J, Wesson DE, et al
    Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
    Am J Nephrol. 2019;49:438-448.
    PubMed     Abstract available


  90. IBARRA-HERNANDEZ M, Alcantar-Vallin ML, Soto-Cruz A, Jimenez-Alvarado PM, et al
    Challenges in Managing Pregnancy in Underserved Women with Chronic Kidney Disease.
    Am J Nephrol. 2019;49:386-396.
    PubMed     Abstract available


  91. KAPOIAN T, Khalil S, O'Mara NB, Brink DM, et al
    Modeled Daily Ingested, Absorbed and Bound Phosphorus: New Measures of Mineral Balance in Hemodialysis Patients.
    Am J Nephrol. 2019;49:368-376.
    PubMed     Abstract available


  92. JOTWANI VK, Lee AK, Estrella MM, Katz R, et al
    Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
    Am J Nephrol. 2019;49:346-355.
    PubMed     Abstract available


    March 2019
  93. MATSCHKAL J, Mayer CC, Sarafidis PA, Lorenz G, et al
    Comparison of 24-hour and Office Pulse Wave Velocity for Prediction of Mortality in Hemodialysis Patients.
    Am J Nephrol. 2019;49:317-327.
    PubMed     Abstract available


  94. RIVERA M, Tamariz L, Suarez M, Contreras G, et al
    Modifying Effect of Statins on Fatal Outcomes in Chronic Kidney Disease Patients in the Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
    Am J Nephrol. 2019;49:297-306.
    PubMed     Abstract available


  95. STRUGNELL SA, Sprague SM, Ashfaq A, Petkovich M, et al
    Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Am J Nephrol. 2019;49:284-293.
    PubMed     Abstract available


  96. AKIZAWA T, Macdougall IC, Berns JS, Bernhardt T, et al
    Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies.
    Am J Nephrol. 2019;49:271-280.
    PubMed     Abstract available


    February 2019
  97. JOVANOVICH A, You Z, Isakova T, Nowak K, et al
    Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
    Am J Nephrol. 2019;49:263-270.
    PubMed     Abstract available


  98. SHAH S, Leonard AC, Meganathan K, Christianson AL, et al
    Temporal Trends in Incident Mortality in Dialysis Patients: Focus on Sex and Racial Disparities.
    Am J Nephrol. 2019;49:241-253.
    PubMed     Abstract available


  99. EMRICH IE, Brandenburg V, Sellier AB, Schauerte J, et al
    Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Am J Nephrol. 2019;49:203-211.
    PubMed     Abstract available


  100. WANDELL P, Carlsson AC, Li X, Gasevic D, et al
    End-Stage Kidney Diseases in Immigrant Groups: A Nationwide Cohort Study in Sweden.
    Am J Nephrol. 2019;49:186-192.
    PubMed     Abstract available


    January 2019
  101. AKIZAWA T, Nangaku M, Yamaguchi T, Arai M, et al
    A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
    Am J Nephrol. 2019;49:165-174.
    PubMed     Abstract available


  102. BYLSMA LC, Reichert H, Gage SM, Roy-Chaudhury P, et al
    Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.
    Am J Nephrol. 2019;49:156-164.
    PubMed     Abstract available


  103. SCHWANTES-AN TH, Liu S, Stedman M, Decker BS, et al
    Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
    Am J Nephrol. 2019;49:125-132.
    PubMed     Abstract available


  104. PRASAD PV, Li LP, Thacker JM, Li W, et al
    Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney Disease.
    Am J Nephrol. 2019;49:114-124.
    PubMed     Abstract available


  105. JIANG K, Lerman LO
    Prediction of Chronic Kidney Disease Progression by Magnetic Resonance Imaging: Where Are We?
    Am J Nephrol. 2019;49:111-113.
    PubMed    


  106. OLANIRAN KO, Eneanya ND, Allegretti AS, Zhao SH, et al
    Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease.
    Am J Nephrol. 2019;49:93-102.
    PubMed     Abstract available


  107. PEREZ FERNANDEZ M, Martinez Miguel P, Ying H, Haugen CE, et al
    Comorbidity, Frailty, and Waitlist Mortality among Kidney Transplant Candidates of All Ages.
    Am J Nephrol. 2019;49:103-110.
    PubMed     Abstract available


  108. KRAHN RE, Tulowitzki R, Gudleski GD, Murray B, et al
    Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.
    Am J Nephrol. 2019;49:74-80.
    PubMed     Abstract available


  109. CHEUNG CK, Barratt J
    Pregnancy in IgA Nephropathy: An Effect on Renal Outcome?
    Am J Nephrol. 2019;49:212-213.
    PubMed    


  110. COURI T, Cotter TG, Chen D, Hammes M, et al
    Use of Hepatitis C Positive Organs: Patient Attitudes in Urban Chicago.
    Am J Nephrol. 2019;49:32-40.
    PubMed     Abstract available


    December 2018
  111. AJMAL F, Probst J, Brooks J, Hardin J, et al
    Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Am J Nephrol. 2018;49:64-73.
    PubMed     Abstract available


  112. DAUBRESSE M, Alexander GC, Crews DC, Segev DL, et al
    Trends in Opioid Prescribing Among Hemodialysis Patients, 2007-2014.
    Am J Nephrol. 2018;49:20-31.
    PubMed     Abstract available


  113. YE X, Kooman JP, van der Sande FM, Canaud B, et al
    Increased Mortality Associated with Higher Pre-Dialysis Serum Sodium Variability: Results of the International MONitoring Dialysis Outcome Initiative.
    Am J Nephrol. 2018;49:1-10.
    PubMed     Abstract available


  114. LEE T, Qian J, Thamer M, Allon M, et al
    Gender Disparities in Vascular Access Surgical Outcomes in Elderly Hemodialysis Patients.
    Am J Nephrol. 2018;49:11-19.
    PubMed     Abstract available


    November 2018
  115. BURROWS NR, Vassalotti JA, Saydah SH, Stewart R, et al
    Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project.
    Am J Nephrol. 2018;48:447-455.
    PubMed     Abstract available


  116. AWAN AA, Niu J, Pan JS, Erickson KF, et al
    Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).
    Am J Nephrol. 2018;48:472-481.
    PubMed     Abstract available


  117. GUILLOTEAU S, Lobbedez T, Guillouet S, Verger C, et al
    Impact of Assisted Peritoneal Dialysis Modality on Outcomes: A Cohort Study of the French Language Peritoneal Dialysis Registry.
    Am J Nephrol. 2018;48:425-433.
    PubMed     Abstract available


  118. FITZPATRICK J, Sozio SM, Jaar BG, McAdams-DeMarco MA, et al
    Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis.
    Am J Nephrol. 2018;48:406-414.
    PubMed     Abstract available


  119. KO GJ, Obi Y, Soohoo M, Chang TI, et al
    No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.
    Am J Nephrol. 2018;48:389-398.
    PubMed     Abstract available


  120. JANSZ TT, van Reekum FE, Ozyilmaz A, de Jong PA, et al
    Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.
    Am J Nephrol. 2018;48:369-377.
    PubMed     Abstract available


    October 2018
  121. LYU B, Banerjee T, Scialla JJ, Shafi T, et al
    Vascular Calcification Markers and Hemodialysis Vascular Access Complications.
    Am J Nephrol. 2018;48:330-338.
    PubMed     Abstract available


  122. BIKOS A, Angeloudi E, Memmos E, Loutradis C, et al
    A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.
    Am J Nephrol. 2018;48:295-305.
    PubMed     Abstract available


  123. KOSMADAKIS G, Albaret J, da Costa Correia E, Somda F, et al
    Gastrointestinal Disorders in Peritoneal Dialysis Patients.
    Am J Nephrol. 2018;48:319-325.
    PubMed     Abstract available


  124. CHEN YJ, Yeung L, Sun CC, Huang CC, et al
    Age-Related Macular Degeneration in Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Am J Nephrol. 2018;48:278-291.
    PubMed     Abstract available


  125. JADOON A, Mathew AV, Byun J, Gadegbeku CA, et al
    Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients.
    Am J Nephrol. 2018;48:269-277.
    PubMed     Abstract available


  126. MACDOUGALL IC, White C, Anker SD, Bhandari S, et al
    Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
    Am J Nephrol. 2018;48:260-268.
    PubMed     Abstract available


    September 2018
  127. AZMANDIAN J, Abbasi MR, Pourfarziani V, Nasiri AA, et al
    Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.
    Am J Nephrol. 2018;48:251-259.
    PubMed     Abstract available


  128. FIRTH C, Shamoun F, Cha S, Zhang N, et al
    Cardiac Troponin T Risk Stratification Model Predicts All-Cause Mortality Following Kidney Transplant.
    Am J Nephrol. 2018;48:242-250.
    PubMed     Abstract available


  129. HAUGEN CE, King EA, Bae S, Bowring MG, et al
    Early Hospital Readmission in Older and Younger Kidney Transplant Recipients.
    Am J Nephrol. 2018;48:235-241.
    PubMed     Abstract available


  130. THADHANI R, Guilatco R, Hymes J, Maddux FW, et al
    Switching from Epoetin Alfa (Epogen(R)) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.
    Am J Nephrol. 2018;48:214-224.
    PubMed     Abstract available


  131. HAYASHI T, Yasuda K, Kimura T, Sasaki K, et al
    Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;48:205-213.
    PubMed     Abstract available


  132. GARZA-MAYERS AC, Shah R, Sykes DB, Nigwekar SU, et al
    The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis.
    Am J Nephrol. 2018;48:168-171.
    PubMed     Abstract available


  133. WARSAME F, Ying H, Haugen CE, Thomas AG, et al
    Intradialytic Activities and Health-Related Quality of Life Among Hemodialysis Patients.
    Am J Nephrol. 2018;48:181-189.
    PubMed     Abstract available


  134. ZOCCALI C, Mallamaci F
    A New Treatment for Calciphylaxis in Hemodialysis Patients?
    Am J Nephrol. 2018;48:165-167.
    PubMed    


  135. AGARWAL R, Rossignol P, Garza D, Mayo MR, et al
    Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study.
    Am J Nephrol. 2018;48:172-180.
    PubMed     Abstract available


  136. SHINFUKU A, Shimazaki T, Fujiwara M, Sato F, et al
    Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers.
    Am J Nephrol. 2018;48:157-164.
    PubMed     Abstract available


    August 2018
  137. KERNS ES, Kim ED, Meoni LA, Sozio SM, et al
    Obstructive Sleep Apnea Increases Sudden Cardiac Death in Incident Hemodialysis Patients.
    Am J Nephrol. 2018;48:147-156.
    PubMed     Abstract available


  138. DAUGIRDAS JT
    Changes in Total Protein Concentration Due to Fluid Removal During and Shortly after Hemodialysis.
    Am J Nephrol. 2018;48:118-126.
    PubMed     Abstract available


  139. DROSOS G, Ampatzidou F, Sarafidis P, Karaiskos T, et al
    Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.
    Am J Nephrol. 2018;48:108-117.
    PubMed     Abstract available


  140. IKENOUE T, Koike K, Fukuma S, Ogata S, et al
    Salt Intake and All-Cause Mortality in Hemodialysis Patients.
    Am J Nephrol. 2018;48:87-95.
    PubMed     Abstract available


  141. MOVILLI E, Camerini C, Gaggia P, Zubani R, et al
    Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Am J Nephrol. 2018;48:79-86.
    PubMed     Abstract available


    July 2018
  142. ZHOU H, Yang M, Jiang Z, Ding J, et al
    Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;48:46-55.
    PubMed     Abstract available


  143. AIRY M, Schold JD, Jolly SE, Arrigain S, et al
    Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.
    Am J Nephrol. 2018;48:36-45.
    PubMed     Abstract available


  144. BOSTOM A, Pasch A, Madsen T, Roberts MB, et al
    Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Am J Nephrol. 2018;48:21-31.
    PubMed     Abstract available


  145. SHAH S, Leonard AC, Meganathan K, Christianson AL, et al
    Gender and Racial Disparities in Initial Hemodialysis Access and Outcomes in Incident End-Stage Renal Disease Patients.
    Am J Nephrol. 2018;48:4-14.
    PubMed     Abstract available


    June 2018
  146. BLUM D, Chan CT
    Iatrogenesis Imperfecta Medicamentosa: Adverse Drug Events in Dialysis Patients are Associated with Higher Resource Utilization and Mortality.
    Am J Nephrol. 2018;47:438-440.
    PubMed    


  147. CHAN L, Saha A, Poojary P, Chauhan K, et al
    National Trends in Emergency Room Visits of Dialysis Patients for Adverse Drug Reactions.
    Am J Nephrol. 2018;47:441-449.
    PubMed     Abstract available


  148. DOSHI S, Wish JB
    Can Emergency Department Visits for Adverse Drug Reactions in Dialysis Patients be Reduced?
    Am J Nephrol. 2018;47:435-437.
    PubMed    


  149. LEE T, Shah S, Leonard AC, Parikh P, et al
    Acute Kidney Injury before Dialysis Initiation Predicts Adverse Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2018;47:427-434.
    PubMed     Abstract available


  150. FERREY A, You AS, Kovesdy CP, Nakata T, et al
    Dialysate Potassium and Mortality in a Prospective Hemodialysis Cohort.
    Am J Nephrol. 2018;47:415-423.
    PubMed     Abstract available


  151. MARUYAMA N, Otsuki T, Yoshida Y, Nagura C, et al
    Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.
    Am J Nephrol. 2018;47:406-414.
    PubMed     Abstract available


  152. GREGG LP, Tio MC, Li X, Adams-Huet B, et al
    Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
    Am J Nephrol. 2018;47:395-405.
    PubMed     Abstract available


    May 2018
  153. YANG X, Tong Y, Yan H, Ni Z, et al
    High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
    Am J Nephrol. 2018;47:317-324.
    PubMed     Abstract available


  154. KLEINE CE, Soohoo M, Ranasinghe ON, Park C, et al
    Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes.
    Am J Nephrol. 2018;47:333-342.
    PubMed     Abstract available


  155. IWASHITA Y, Ohya M, Yashiro M, Sonou T, et al
    Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.
    Am J Nephrol. 2018;47:325-332.
    PubMed     Abstract available


    April 2018
  156. ZOCCALI C, Mallamaci F
    Obestatin, a Ghrelin-Cognate Protein, and Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2018;47:251-253.
    PubMed    


  157. BEBERASHVILI I, Katkov A, Sinuani I, Azar A, et al
    Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
    Am J Nephrol. 2018;47:254-265.
    PubMed     Abstract available


  158. CHAN CT, Kaysen GA, Beck GJ, Li M, et al
    Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Am J Nephrol. 2018;47:208-217.
    PubMed     Abstract available


    March 2018
  159. NORMAND G, Xu X, Panaye M, Jolivot A, et al
    Pregnancy Outcomes in French Hemodialysis Patients.
    Am J Nephrol. 2018;47:219-227.
    PubMed     Abstract available


  160. TAN J, Mehrotra A, Nadkarni GN, He JC, et al
    Telenephrology: Providing Healthcare to Remotely Located Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:200-207.
    PubMed     Abstract available


  161. CHEN W, Bushinsky DA
    Addressing Racial Disparity in the Progression of Chronic Kidney Disease: Prescribe More Fruits and Vegetables?
    Am J Nephrol. 2018;47:171-173.
    PubMed    


  162. CREWS DC, Banerjee T, Wesson DE, Morgenstern H, et al
    Race/Ethnicity, Dietary Acid Load, and Risk of End-Stage Renal Disease among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:174-181.
    PubMed     Abstract available


  163. KALANTAR-ZADEH K, Parameswaran V, Ficociello LH, Anderson L, et al
    Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
    Am J Nephrol. 2018;47:153-161.
    PubMed     Abstract available


    February 2018
  164. PATZER RE, Basu M, Smith KD, Plantinga L, et al
    Awareness of the New Kidney Allocation System among United States Dialysis Providers with Low Waitlisting.
    Am J Nephrol. 2018;47:115-119.
    PubMed     Abstract available


  165. KIM JK, Song YR, Lee HS, Kim HJ, et al
    Repeated Bioimpedance Measurements Predict Prognosis of Peritoneal Dialysis Patients.
    Am J Nephrol. 2018;47:120-129.
    PubMed     Abstract available


  166. WISH JB, Aronoff GR, Bacon BR, Brugnara C, et al
    Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?
    Am J Nephrol. 2018;47:72-83.
    PubMed     Abstract available


  167. SINGH M, Raghavan D, Williams JS, Martin BC, et al
    Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans.
    Am J Nephrol. 2018;47:67-71.
    PubMed     Abstract available


    January 2018
  168. SUMIDA K, Yamamoto S, Akizawa T, Fukuhara S, et al
    Body Mass Index Change and Hospitalization Risk in Elderly Hemodialysis Patients: Results from Japanese Dialysis Outcomes and Practice Patterns Study.
    Am J Nephrol. 2018;47:48-56.
    PubMed     Abstract available


  169. CHIN MP, Bakris GL, Block GA, Chertow GM, et al
    Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
    Am J Nephrol. 2018;47:40-47.
    PubMed     Abstract available


  170. TRIEBSWETTER S, Gutjahr-Lengsfeld LJ, Schmidt KR, Drechsler C, et al
    Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Am J Nephrol. 2018;47:30-39.
    PubMed     Abstract available


    December 2017
  171. DIVANI M, Georgianos PI, Didangelos T, Iliadis F, et al
    Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Am J Nephrol. 2017;47:21-29.
    PubMed     Abstract available


  172. MOLITCH ME
    Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?
    Am J Nephrol. 2017;47:18-20.
    PubMed    


  173. JONES D, You Z, Kendrick JB
    Racial/Ethnic Differences in Barriers to Kidney Transplant Evaluation among Hemodialysis Patients.
    Am J Nephrol. 2017;47:1-7.
    PubMed     Abstract available


  174. MC CAUSLAND FR, Claggett B, Pfeffer MA, Burdmann EA, et al
    Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
    Am J Nephrol. 2017;46:488-497.
    PubMed     Abstract available


    November 2017
  175. KIDO R, Akizawa T, Fukagawa M, Onishi Y, et al
    Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients.
    Am J Nephrol. 2017;46:439-447.
    PubMed     Abstract available


  176. SUMIDA K, Diskin CD, Molnar MZ, Potukuchi PK, et al
    Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.
    Am J Nephrol. 2017;46:397-407.
    PubMed     Abstract available


  177. CATABAY C, Obi Y, Streja E, Soohoo M, et al
    Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients.
    Am J Nephrol. 2017;46:408-416.
    PubMed     Abstract available


  178. MALHOTRA R, Tao X, Wang Y, Chen Y, et al
    Performance of the Surprise Question Compared to Prediction Models in Hemodialysis Patients: A Prospective Study.
    Am J Nephrol. 2017;46:390-396.
    PubMed     Abstract available


  179. TOMINAGA N, Kida K, Inomata T, Sato N, et al
    Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
    Am J Nephrol. 2017;46:417-426.
    PubMed     Abstract available


    October 2017
  180. WEIR MR, Pergola PE, Agarwal RL, Fink JC, et al
    A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:364-370.
    PubMed     Abstract available


  181. MADUELL F, Varas J, Ramos R, Martin-Malo A, et al
    Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.
    Am J Nephrol. 2017;46:288-297.
    PubMed     Abstract available


  182. LAM NN, Garg AX, Knoll GA, Kim SJ, et al
    Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
    Am J Nephrol. 2017;46:343-354.
    PubMed     Abstract available


    September 2017
  183. SAULNIER PJ, Dieter BP, Tanamas SK, McPherson SM, et al
    Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Am J Nephrol. 2017;46:276-284.
    PubMed     Abstract available


  184. MUREA M, Brown WM, Divers J, Moossavi S, et al
    Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study.
    Am J Nephrol. 2017;46:268-275.
    PubMed     Abstract available


  185. LEONBERG-YOO AK, Rudnick MR
    Tobacco Use: A Chronic Kidney Disease Accelerant.
    Am J Nephrol. 2017;46:257-259.
    PubMed    


  186. ROEHM B, Simoni J, Pruszynski J, Wesson DE, et al
    Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
    Am J Nephrol. 2017;46:260-267.
    PubMed     Abstract available


  187. LIN MC, Streja E, Soohoo M, Hanna M, et al
    Warfarin Use and Increased Mortality in End-Stage Renal Disease.
    Am J Nephrol. 2017;46:249-256.
    PubMed     Abstract available


    August 2017
  188. HARDING K, Mersha TB, Pham PT, Waterman AD, et al
    Health Disparities in Kidney Transplantation for African Americans.
    Am J Nephrol. 2017;46:165-175.
    PubMed     Abstract available


    May 2017
  189. FERREIRA A, Felipe C, Cristelli M, Viana L, et al
    Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Am J Nephrol. 2017;45:497-508.
    PubMed     Abstract available


    January 2017
  190. KOVESDY CP, Furth SL, Zoccali C
    Obesity and Kidney Disease: Hidden Consequences of the Epidemic.
    Am J Nephrol. 2017;45:283-291.
    PubMed     Abstract available


  191. PAYAN SCHOBER F, Jobson MA, Poulton CJ, Singh HK, et al
    Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis.
    Am J Nephrol. 2017;45:248-256.
    PubMed     Abstract available


  192. COLLISTER D, Sathianathan C, Ryz K, Karpinski M, et al
    ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series.
    Am J Nephrol. 2017;45:209-216.
    PubMed     Abstract available


  193. SARAFIDIS PA
    Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?
    Am J Nephrol. 2017;46:285-287.
    PubMed    


  194. QIU W, Jiang Y, Wu J, Huang H, et al
    Simple Cysts in Donor Kidney Contribute to Reduced Allograft Function.
    Am J Nephrol. 2017;45:82-88.
    PubMed     Abstract available


  195. HEMPEL JC, Poppelaars F, Gaya da Costa M, Franssen CF, et al
    Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
    Am J Nephrol. 2017;45:49-59.
    PubMed     Abstract available


    December 2016
  196. TABER DJ, Fleming JN, Fominaya CE, Gebregziabher M, et al
    The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.
    Am J Nephrol. 2016;45:91-98.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: